| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1440085B1 Transient immortalization of cells by oncogenic proteins or telomerase |
| 04/14/2010 | EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1363636B1 A combination comprising levosimendan and a calcium source for the treatment of heart failure |
| 04/14/2010 | EP1347773B1 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1953749B Application of 1-(substituted phenyl)-5-methyl-2-(1H)-pyridone (I) compound in preparing medicine for anti-organifibrosis or tissue fibrosis |
| 04/14/2010 | CN1951434B Soft capsule having fatigue-resisting radiation-resisting function and preparation method thereof |
| 04/14/2010 | CN1465338B Skin activating composition for external used anti-aging preparation |
| 04/14/2010 | CN1360592B Streptogramin derivs., production thereof and composition containing same |
| 04/14/2010 | CN101693742A anti-igf-i receptor antibody |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693709A Bicyclic amides as kinase inhibitors |
| 04/14/2010 | CN101693672A Peptidomimetic protease inhibitors |
| 04/14/2010 | CN101693070A Traditional Chinese medicine composition for treating fowl heat stress syndrome and method for preparing the composition |
| 04/14/2010 | CN101693031A Inhibitors of the mutant form of KIT |
| 04/14/2010 | CN101693016A Universal pharmaceutical formulation for recombined human serum albumin fusion proteins for injection |
| 04/14/2010 | CN101693015A Coenzyme A medicament freeze-drying preparation and process for preparing same |
| 04/14/2010 | CN101693014A Process for preparing coenzyme A medicament freeze drying preparation |
| 04/13/2010 | USRE41226 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/13/2010 | US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders |
| 04/13/2010 | US7696331 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 04/13/2010 | US7696317 Mammalian genes; related reagents and methods |
| 04/13/2010 | US7696313 Prodrug compounds with isoleucine |
| 04/13/2010 | US7696247 Lipid-based nitric oxide donors |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/13/2010 | US7696194 Visual function disorder improving agents |
| 04/13/2010 | US7696190 16Alpha-methyl or ethyl substituted estrogens |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity |
| 04/13/2010 | US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/13/2010 | US7695902 Contacting test solution containing Rna and enzyme; hybridization |
| 04/13/2010 | US7695742 Plant extract mixtures and their uses |
| 04/13/2010 | US7695741 Cavalia gladiata, Biota orientalis and Coptis chinensis very effective in prevention and treatment of acnes and have very little or no irritation; microbiocides; sebum ihibitors; keratolysis; antiinflammatory agents; enzyme inhibitors of 5-alpha-reductase; Chinese herbal medicine |
| 04/13/2010 | CA2486001C Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 04/13/2010 | CA2465062C Preventive and/or therapeutic agent for viral infection |
| 04/13/2010 | CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2431308C Regulation of angiogenesis with zinc finger proteins |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2408707C Compositions and methods for the treatment of cancer |
| 04/13/2010 | CA2394229C Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 04/13/2010 | CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/13/2010 | CA2348773C Functional antagonists of hedgehog activity |
| 04/13/2010 | CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2330206C Poly(adp-ribose) polymerase gene |
| 04/13/2010 | CA2318482C Il-18 receptors |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039510A2 Use of syndyphalin-33 (sd-33; try-dmet(o)-gly-methylphenylethylamide) as a therapeutic agent to enhance the health and well-being of newly-weaned animals |
| 04/08/2010 | WO2010038901A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative |
| 04/08/2010 | WO2010038895A1 Casr agonist |
| 04/08/2010 | WO2010038874A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
| 04/08/2010 | WO2010038842A1 Novel polyphenol compound |
| 04/08/2010 | WO2010038803A1 2-indoleacrylamide analogue |
| 04/08/2010 | WO2010038796A1 Therapeutic agent for hepatitis c |
| 04/08/2010 | WO2010038686A1 Novel fused aminodihydrothiazine derivative |
| 04/08/2010 | WO2010038610A1 Novel cartilage cell proliferation and differentiation inducer |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process |
| 04/08/2010 | WO2010038428A1 Alternative agent to taxane anti-cancer agent |
| 04/08/2010 | WO2010037352A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen |
| 04/08/2010 | US20100087624 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/08/2010 | US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 04/08/2010 | US20100087546 Use of dimethyl sulfone (msm) to reduce homocysteine levels |
| 04/08/2010 | US20100087524 Flavour Improving Substances |
| 04/08/2010 | US20100087519 Use of equol for treating androgen mediated diseases |
| 04/08/2010 | US20100087490 Dosage Units of 3-(6-(1-(2,2-Difluorobenzo[D] [1,3] Dioxol-5-YL) Cyclopropanecarboxamido)-3-Methylpyridin-2-YL)Benzoic Acid |
| 04/08/2010 | US20100087435 Modulators of atp-binding cassette transporters |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 04/08/2010 | US20100087411 Substituted sapogenins and their use |
| 04/08/2010 | US20100087379 Polypeptides of botryosphaeria rhodina |
| 04/08/2010 | US20100086594 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/08/2010 | US20100086560 Chemokines as adjuvants of immune response |
| 04/08/2010 | US20100086533 Laglidadg homing endonuclease variants having novel substrate specificity and use thereof |
| 04/08/2010 | US20100086532 Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| 04/08/2010 | US20100086523 Method for generating pluripotent stem cells |
| 04/08/2010 | US20100086490 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | CA2739513A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative |
| 04/08/2010 | CA2739505A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculosis agent |
| 04/08/2010 | CA2738993A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-releasing hormone (gnrh) as immunogen |
| 04/08/2010 | CA2738985A1 Therapeutic agent for hepatitis c |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2738150A1 Novel fused aminodihydrothiazine derivative |
| 04/07/2010 | EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 04/07/2010 | EP2172544A1 Novel adamts-13 mutant |
| 04/07/2010 | EP2172478A2 Activity-dependent neurotrophic factor III (ADNF III) |
| 04/07/2010 | EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |
| 04/07/2010 | EP2172447A1 Amide compound |
| 04/07/2010 | EP2172246A2 Methods for Alzheimer's disease treatment and cognitive enhancement |